GlassScriptPhysician profile
Sandra P Palomino
NPI 1518006477
$4,550.33
in general payments reported to CMS, 2019-2025
11 companies · $1,854 in 2025
The $1,854 reported for 2025 was more than what 96% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,604 · 2020: $78.04 · 2021: $119 · 2022: $496 · 2023: $233 · 2024: $166 · 2025: $1,854.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,253.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,253.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lumenis Be INC | $1,697.55 | 2025 | M22 |
| Johnson & Johnson Vision Care, INC. | $1,264.30 | 2019-2023 | Acuvue |
| Alcon Vision LLC | $552.48 | 2019-2025 | Precision7, Total30 |
| Bausch & Lomb Americas INC. | $310.00 | 2022-2024 | Infuse, Biotrue One Day, Miebo |
| Heru, INC. | $205.97 | 2022 | |
| Optos, INC. | $176.57 | 2019 | |
| Coopervision INC. | $139.02 | 2023 | Misight Contact Lens, Myday Contact Lens |
| Rxsight INC | $97.30 | 2021 | |
| Johnson & Johnson Surgical Vision, INC. | $57.41 | 2019 | |
| Sight Sciences, INC. | $31.79 | 2020 | |
| Abb Con-Cise Optical Group LLC | $17.94 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandra Palomino listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.